Question 1

Is Pancreatina Amilasa + Lipasa + Proteasas Totales currently in shortage?

Accepted Answer

Yes. As of the latest regulator updates, Pancreatina Amilasa + Lipasa + Proteasas Totales has 3 active shortage notices across 2 countries (Colombia, Portugal). Status is refreshed daily from official regulatory sources.

Question 2

Why is Pancreatina Amilasa + Lipasa + Proteasas Totales in shortage?

Accepted Answer

Regulators attribute the current Pancreatina Amilasa + Lipasa + Proteasas Totales shortages to supply-chain disruption, causes not stated by the regulator. The exact cause varies by country and product — each notice on this page links to the official source.

Question 3

Where does this Pancreatina Amilasa + Lipasa + Proteasas Totales shortage data come from?

Accepted Answer

Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.

Country	Severity	Notices	Since	Est. resolution	Source
Colombia	high	1	11 Oct 2022	—	INVIMA
Portugal	medium	2	5 Jul 2026	—	INFARMED

Pancreatina Amilasa + Lipasa + Proteasas Totales shortage status

Where Pancreatina Amilasa + Lipasa + Proteasas Totales is in shortage

Why Pancreatina Amilasa + Lipasa + Proteasas Totales is in shortage

Frequently asked questions

Get alerted when Pancreatina Amilasa + Lipasa + Proteasas Totales status changes